表紙:旅行用ワクチンの世界市場 - 産業規模、シェア、動向、機会、予測:組成別、疾患症状別、旅行タイプ別、地域別(2017年~2027年)
市場調査レポート
商品コード
1152255

旅行用ワクチンの世界市場 - 産業規模、シェア、動向、機会、予測:組成別、疾患症状別、旅行タイプ別、地域別(2017年~2027年)

Travel Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition, By Disease Indication, By Travel Type and By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

旅行用ワクチンの世界市場 - 産業規模、シェア、動向、機会、予測:組成別、疾患症状別、旅行タイプ別、地域別(2017年~2027年)
出版日: 2022年11月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の旅行用ワクチンの市場規模は、予測期間中の2023年~2027年に安定した速度で成長すると予測されています。

市場成長は、インフルエンザ発症率の上昇と、旅行・観光部門の急成長によるものです。さらに、固有種や国境を越えた感染症予防への意識の高まりや、感染症の増大を防ぐための保健当局による厳しい勧告・規制も、旅行用ワクチンの採用を後押しする要因となっています。また、COVID-19の大流行により、感染拡大を防ぐために旅行用ワクチンが重視されるようになり、一般市民の感染症拡大への認識と警戒が高まっていることで、旅行用ワクチンの需要は今後数年間で急増する見込みです。

当レポートでは、世界の旅行用ワクチン市場について調査分析し、セグメント別・地域別の市場規模・シェア予測、市場力学、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の旅行用ワクチン市場に対するCOVID-19の影響

第5章 VOC(顧客の声)

  • 旅行用ワクチンへの関心
  • 旅行用ワクチン:地域別
  • 旅行用ワクチン:旅行タイプ別

第6章 世界の旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別(単剤ワクチンと混合ワクチン)
    • 疾患症状別(A型肝炎、DPT、黄熱病、腸チフス、B型肝炎、麻疹・おたふくかぜ、狂犬病、髄膜炎菌、水痘、日本脳炎、その他)
    • 旅行タイプ別(国内と海外)
    • 地域別
  • 製品市場マップ

第7章 北米の旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別
    • 疾患症状別
    • 旅行タイプ別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州の旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別
    • 疾患症状別
    • 旅行タイプ別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋の旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別
    • 疾患症状別
    • 旅行タイプ別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア
    • シンガポール

第10章 南米の旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別
    • 疾患症状別
    • 旅行タイプ別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの旅行用ワクチン市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 組成別
    • 疾患症状別
    • 旅行タイプ別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE
    • イスラエル
    • トルコ

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開発

第14章 競合情勢

  • GlaxoSmithKline, plc.
  • Sanofi S.A.
  • Novartis International AG
  • Merck KGaA
  • Pfizer Inc.
  • AstraZeneca Plc.
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • CSL Limited
  • Johnson & Johnson

第15章 戦略的提言

目次
Product Code: 12838

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector. Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses. Vaccines work by exposing the body to germs of the disease it will protect against by enabling the production of antibodies. Besides, increasing awareness regarding the prevention of endemics and transnational infections and stringent advisories and regulations by health authorities to prevent the rise of infectious diseases are some of the factors driving the adoption of travel vaccines. The travel and tourism industry has witnessed a robust growth in recent years with the rise in disposable income of middle-class population across the world. Moreover, increasing trend of exploring different cultures, traditions, spiritualism, rural and ethnic living is propelling the adoption of travel vaccines. The COVID-19 pandemic has led to an increased emphasis on travel vaccines to avoid the spread of infections. As the public is becoming more aware and alert around the spread of infectious diseases, the demand for travel vaccine is expected to proliferate in the coming years. Growth in tourism activities have also led to the booming travel vaccine business for market players.

Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth

Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

High Market Growth Potential in Emerging Nations

Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.

Market Segmentation

The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.

Market Players

Key players operating in the global travel vaccine market are: GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.

Report Scope:

In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Travel Vaccine Market, By Composition:

  • Mono Vaccines
  • Combination Vaccines

Travel Vaccine Market, By Disease Indication:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Travel Vaccine Market, By Type:

  • Domestic
  • International

Travel Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Singapore
    • South Korea
  • Europe & CIS
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Israel
    • UAE
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Travel Vaccine Market

5. Voice of Customer

  • 5.1. Travel Vaccination Awareness
  • 5.2. Travel Vaccination, By Region
  • 5.3. Travel Vaccination, By Travel Type

6. Global Travel Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Composition (Mono Vaccines v/s Combination Vaccines)
    • 6.2.2. By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
    • 6.2.3. By Travel Type (Domestic v/s International)
    • 6.2.4. By Region
  • 6.3. Product Market Map

7. North America Travel Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Composition
    • 7.2.2. By Disease Indication
    • 7.2.3. By Travel Type
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Travel Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Composition
        • 7.3.1.2.2. By Disease Indication
        • 7.3.1.2.3. By Travel Type
    • 7.3.2. Mexico Travel Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Composition
        • 7.3.2.2.2. By Disease Indication
        • 7.3.2.2.3. By Travel Type
    • 7.3.3. Canada Travel Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Composition
        • 7.3.3.2.2. By Disease Indication
        • 7.3.3.2.3. By Travel Type

8. Europe Travel Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Composition
    • 8.2.2. By Disease Indication
    • 8.2.3. By Travel Type
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Travel Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Composition
        • 8.3.1.2.2. By Disease Indication
        • 8.3.1.2.3. By Travel Type
    • 8.3.2. Germany Travel Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Composition
        • 8.3.2.2.2. By Disease Indication
        • 8.3.2.2.3. By Travel Type
    • 8.3.3. United Kingdom Travel Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Composition
        • 8.3.3.2.2. By Disease Indication
        • 8.3.3.2.3. By Travel Type
    • 8.3.4. Italy Travel Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Composition
        • 8.3.4.2.2. By Disease Indication
        • 8.3.4.2.3. By Travel Type
    • 8.3.5. Spain Travel Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Composition
        • 8.3.5.2.2. By Disease Indication
        • 8.3.5.2.3. By Travel Type

9. Asia-Pacific Travel Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Composition
    • 9.2.2. By Disease Indication
    • 9.2.3. By Travel Type
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Travel Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Composition
        • 9.3.1.2.2. By Disease Indication
        • 9.3.1.2.3. By Travel Type
    • 9.3.2. India Travel Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Composition
        • 9.3.2.2.2. By Disease Indication
        • 9.3.2.2.3. By Travel Type
    • 9.3.3. South Korea Travel Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Composition
        • 9.3.3.2.2. By Disease Indication
        • 9.3.3.2.3. By Travel Type
    • 9.3.4. Japan Travel Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Composition
        • 9.3.4.2.2. By Disease Indication
        • 9.3.4.2.3. By Travel Type
    • 9.3.5. Australia Travel Vaccine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Composition
        • 9.3.5.2.2. By Disease Indication
        • 9.3.5.2.3. By Travel Type
    • 9.3.6. Singapore Travel Vaccine Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Composition
        • 9.3.6.2.2. By Disease Indication
        • 9.3.6.2.3. By Travel Type

10. South America Travel Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Composition
    • 10.2.2. By Disease Indication
    • 10.2.3. By Travel Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Travel Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Composition
        • 10.3.1.2.2. By Disease Indication
        • 10.3.1.2.3. By Travel Type
    • 10.3.2. Argentina Travel Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Composition
        • 10.3.2.2.2. By Disease Indication
        • 10.3.2.2.3. By Travel Type
    • 10.3.3. Colombia Travel Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Composition
        • 10.3.3.2.2. By Disease Indication
        • 10.3.3.2.3. By Travel Type

11. Middle East and Africa Travel Vaccine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Composition
    • 11.2.2. By Disease Indication
    • 11.2.3. By Travel Type
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Travel Vaccine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Composition
        • 11.3.1.2.2. By Disease Indication
        • 11.3.1.2.3. By Travel Type
    • 11.3.2. Saudi Arabia Travel Vaccine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Composition
        • 11.3.2.2.2. By Disease Indication
        • 11.3.2.2.3. By Travel Type
    • 11.3.3. UAE Travel Vaccine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Composition
        • 11.3.3.2.2. By Disease Indication
        • 11.3.3.2.3. By Travel Type
    • 11.3.4. Israel Travel Vaccine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Composition
        • 11.3.4.2.2. By Disease Indication
        • 11.3.4.2.3. By Travel Type
    • 11.3.5. Turkey Travel Vaccine Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Composition
        • 11.3.5.2.2. By Disease Indication
        • 11.3.5.2.3. By Travel Type

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

  • 14.1. GlaxoSmithKline, plc.
  • 14.2. Sanofi S.A.
  • 14.3. Novartis International AG
  • 14.4. Merck KGaA
  • 14.5. Pfizer Inc.
  • 14.6. AstraZeneca Plc.
  • 14.7. Abbott Laboratories, Inc.
  • 14.8. F. Hoffmann-La Roche AG
  • 14.9. CSL Limited
  • 14.10. Johnson & Johnson

15. Strategic Recommendations